(Exact name of registrant as specified in its charter.)
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
(Address of principal executive offices)
(Registrant's Telephone number)
(Former Name or Former Address, if Changed Since Last Report)
See Item 3.02.
On January 25, 2019, Vivos, Inc. (the "Company") completed a first closing of a private placement consisting of (i) 19,000,000 shares of common stock of the Company for $.005 per share (or shares of Series B Convertible Preferred Stock ("Series B Preferred") for those purchasers who would own in excess of 4.99% of the total number of common shares issued and outstanding at the time of issuance), and (ii) warrants exercisable for 9,500,000 shares of common stock ("Warrants") with a term of two years and an exercise price of $0.01 per share (a form of which Warrant is attached as Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission ("SEC") on October 16, 2018) resulting in gross proceeds to the Company of $95,000 through January 31, 2019 (the "Private Placement"). Assuming the maximum amount in the Private Placement is sold, resulting in gross proceeds to the Company of $400,000, the Company would issue a total of 80,000,000 shares of common stock (or shares of Series B Preferred) and Warrants exercisable for 40 million shares of common stock.
The securities were issued pursuant to a securities purchase agreement, the form of which is attached as Exhibit 10.1 to the Company's current report on Form 8-K filed with the SEC on October 16, 2018.
The shares of common stock or Series B Preferred, as the case may be, and Warrants (together, the "Securities"), were issued and sold without registration and are subject to restrictions under the Securities Act of 1933, as amended, and the securities laws of certain states, in reliance on the private offering exemption contained in Section 4(a)(2) of the Securities Act of 1933, as amended, and on Regulation D promulgated thereunder, and in reliance on similar exemptions under applicable state laws as a transaction not involving a public offering. Gross proceeds from the issuance and sale of Securities in the Private Placement will be used for working capital purposes.
See the Form of Warrant and Securities Purchase Agreement, attached as Exhibits 4.1 and 10.1, respectively, to the Company's Current Report on Form 8-K, filed with the SEC on October 16, 2018.
Vivos Inc. |
By: | /s/ Michael K. Korenko |
Name: Michael K. Korenko | |
Title: Chief Executive Officer |